Cite

HARVARD Citation

    Loessner, D. et al. (n.d.). Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer. Expert opinion on therapeutic targets. pp. 745-763. [Online]. 
  
Back to record